Abstract
Neoplastic fever, a paraneoplastic syndrome caused by cancer itself, represents a diagnostic challenge for the clinician and is an important issue in supportive oncology. Timely recognition of this febrile condition by differentiating it from other cancer-associated fevers, such as infection and drug reaction, is essential for effective patient management. Although the pathophysiology of neoplastic fever is not well understood, it is suspected to be cytokine mediated. In clinical practice, when a patient with cancer presents with unexplained fever, extensive diagnostic studies are needed to differentiate neoplastic fever from nonneoplastic fever. Only after excluding identifiable etiologies of fever can the diagnosis of neoplastic fever be suspected. According to our experience, the naproxen test is a safe and useful test in differentiating neoplastic fever from infectious fever in patients with cancer. In addition, naproxen and other nonsteroidal anti-inflammatory drugs have been effective in the management of neoplastic fever and offer a significant palliative benefit for the patient.
Similar content being viewed by others
References
Anonymous (2002) Leukine (sargramostim). Package Insert Rev 0230-0233:1–2
Anonymous (2002) Neupogen (filgrastim). Physician Package Insert 1–29
Arnow PM, Flaherty JP (1997) Fever of unknown origin. Lancet 350:575–580
Ashford RF, McLachlan A, Nelson I, Mughal T, Pickering, D (1980) Pyrexia after cisplatin. Lancet 2:691–692
Beaupre DM, Talpaz M, Marini FC III, Cristiano RJ, Roth JA, Estrov Z, Albitar M, Freedman MH, Kurzrock R (1999) Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS. Cancer Res 59:2971–2980
Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF (1992) Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52:3317–3322
Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Negrier S, Philip T, Favrot M (1997) Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 72:424–430
Bodel P (1974) Generalized perturbations in host physiology caused by localized tumors. Tumors and fever. Ann N Y Acad Sci 230:6–13
Bodel P, Ralph P, Wenc K, Long JC (1980) Endogenous pyrogen production by Hodgkin’s disease and human histiocytic lymphoma cell lines in vitro. J Clin Invest 65:514–518
Bondy PK, Bodel P (1971) Mechanism of action of pyrogenic and antipyretic steroids in vitro. Ciba Found Symp 101–113
Boye J, Elter T, Engert A (2003) An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 14:520–535
Browder AA, Huff JW, Petersdorf RG (1961) The significance of fever in neoplastic disease. Ann Intern Med 55:932–942
Carter JJ, McLaughlin ML, Bern MM (1983) Bleomycin-induced fatal hyperpyrexia. Am J Med 74:523–525
Cashman TM, Starns RJ, Johnson J, Oren J (1979) Comparative effects of naproxen and aspirin on fever in children. J Pediatr 95:626–629
Chang JC (1987) How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test. Heart Lung 16:122–127
Chang JC (1988) Antipyretic effect of naproxen and corticosteroids on neoplastic fever. J Pain Symptom Manage 3:141–144
Chang JC (1989) Naproxen test in the differential diagnosis of fever of undetermined origin in patients with cancer. Cancer Ther Control 1:57–66
Chang JC (1989) Neoplastic fever. A proposal for diagnosis. Arch Intern Med 149:1728–1730
Chang JC, Appleby J, Bennett JM (1974) Nitroblue tetrazolium test in Hodgkin disease and other malignant lymphomas. Arch Intern Med 133:401–403
Chang JC, Gross HM (1984) Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med 76:597–603
Chang JC, Gross HM (1985) Neoplastic fever responds to the treatment of an adequate dose of naproxen. J Clin Oncol 3:552–558
Chung KF, Snashall PD (1983) Suppression of prolonged fever during treatment of pulmonary tuberculosis: importance of using twice versus single daily dose of prednisolone. Postgrad Med J 59:373–375
Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325(3):164–170
Cunha BA (1996) Fever of unknown origin. Infect Dis Clin North Am 10:111–127
Dinarello CA, Wolff SM (1978) Pathogenesis of fever in man. N Engl J Med 298:607–612
Dinarello CA, Bunn PA (1997) Fever. Semin Oncol 24(3):288–298
Economos K, Lucci JA III, Richardson B, Yazigi R, Miller DS (1995) The effect of naproxen on fever in patients with advanced gynecologic malignancies. Gynecol Oncol 56:250–254
Fauci AS, Dale DC, Balow JE (1976) Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84:304–315
Feigin RD, Shackelford PG, Choi SC, Flake KK, Franklin FA Jr, Eisenberg CS (1971) Nitroblue tetrazolium dye test as an aid in the differential diagnosis of febrile disorders. J Pediatr 78:230–237
Green HD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI, Samonigg H, Clemens MR, Zani V, Liang BC, Renwick J, Piccart MJ (2003) A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol 14:29–35
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KVI, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730–751
Ishii E, Hara T, Mizuno Y, Ueda K (1988) Vincristine-induced fever in children with leukemia and lymphoma. Cancer 61:660–662
Jacoby GA, Swartz MN (1973) Fever of undetermined origin. N Engl J Med 289:1407–1410
Janssens AM, Offner FC, Van Hove WZ (2000) Bone marrow necrosis. Cancer 88:1769–1780
Johnson M (1996) Neoplastic fever. Palliat Med 10:217–224
Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364:2021–2029
Kallio R, Bloigu A, Surcel HM, Syrjala H (2001) C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer 9:124–128
Kathula SK, Shah K, Polenakovik H, Koduri J (2003) Cyclo-oxygenase II inhibitors in the treatment of neoplastic fever. Support Care Cancer 11:258–259
Keinanen-Kiukaanniemi S, Simila S, Kouvalainen K (1980) Oral antipyretic therapy evaluation of the propionic acid derivatives ibuprofen, ketoprofen, fenoprofen and naproxen. Padiatr Padol 15:139–144
Klastersky J (1971) Effectiveness of adrenal corticosteroids in the management of severe bacterial infections. Rev Eur Etud Clin Biol 16:413–417
Knupp C, Pekala PH, Cornelius P (1988) Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasma. Am J Hematol 29(4):215–221
Kurzrock R (2001) The role of cytokines in cancer-related fatigue. Cancer 92:1684–1688
Lobell M, Boggs DR, Wintrobe MM (1966) The clinical significance of fever in Hodgkin’s disease. Arch Intern Med 117:335–342
Lusch CJ, Serpick AA, Slater L (1968) Antipyretic effect of indomethacin in patients with malignancy. Cancer 21:781–786
Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, Siakantaris MP (2001) Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders. Med Oncol 18:99–107
Park BH, Fikrig SM, Smithwick EM (1968) Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid. Lancet 2:532–534
Petersdorf RG (1965) Fever and cancer. Hosp Med 1:2–5
Plaisance KI, Mackowiak PA (2000) Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med 160:449–456
Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU (1986) Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 4:234–243
Rawlins MD, Luff RH, Cranston WI (1970) Pyrexia in renal carcinoma. Lancet 1:1371–1373
Schimpff SC (1986) Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med 80:13–20
Seymour JF, Talpaz M, Cabanillas F, Wetzler M, Kurzrock R (1995) Serum interleukin-6 levels correlate with prognosis in diffuse lareg cell lymphoma. J Clin Oncol 13:575–582
Shah KA, Greenwald E, Levin J, Rosen N, Zumoff B (1982) Streptozocin-induced eosinophilia and fever: a case report. Cancer Treat Rep 66:1449–1451
Smithson WA, Gronert GA, Moss KK (1983) Dantrolene and potentially fatal hyperthermia secondary to L-asparaginase. Cancer Treat Rep 67:318–319
Sokal JE, Shimaoka K (1967) Pyrogen in the urine of febrile patients with Hodgkin’s disease. Nature 215:1183–1185
Tsavaris N, Zinelis A, Karabelis A, Beldecos D, Bacojanis C, Milonacis N, Karvounis N, Kosmidis P (1990) A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever. J Intern Med 228:451–455
Trillet-Lenoir V, Green J, Manegold C, Von Pawel J, Gatzemeier U, Lebeau B, Depierre A, Johnson P, Decoster G, Tomita D (1993) Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 29A(3):319–324
Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, Blockmans D, Bobbaers H (2003) From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med 163:1033–1041
Vanderschueren S, Knockaert DC, Peetermans WE, Bobbaers HJ (2003) Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses. Am J Med 115:572–575
Vasser Stats (2004) Clinical calculator 1. From an observed sample: estimates of population prevalence, sensitivity, specificity, predictive values, and likelihood ratios. http://faculty.vassar.edu/lowry/clin1.html
Wolfe LS, Pappius HM, Marion J (1976) The biosynthesis of prostaglandins by brain tissue in vitro. Adv Prostaglandin Thromboxane Res 1:345–355
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zell, J.A., Chang, J.C. Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer 13, 870–877 (2005). https://doi.org/10.1007/s00520-005-0825-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-005-0825-4